| UniProt/SwissProt ID: | VIGLN_HUMAN |
| Description: | high density lipoprotein binding protein [Source:HGNC Symbol;Acc:4857] |
| Location: | chr2 q37.3 |
| Node attribute: | substrate |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| T671 | NSLIGtKGRLI | HPRD | |
| S667 | AKLHNsLIGTK | KH_1 | PhosphoSitePlus |
| S1223 | EAKAPsRGFVV | PhosphoSitePlus; HPRD; phosphoELM | |
| S904 | ITRDFsVQIKF | KH_1 | PhosphoSitePlus |
| S31 | VATLNsEEESD | PhosphoSitePlus; HPRD; phosphoELM | |
| S368 | SFTVSsVAAPS | KH_1 | PhosphoSitePlus |
| T671 | NSLIGtKGRLI | KH_1 | PhosphoSitePlus |
| S944 | DCDPGsPRRCD | HPRD; phosphoELM | |
| S944 | DCDPGsPRRCD | KH_1 | PhosphoSitePlus |
| Y40 | SDPPTyKDAFP | PhosphoSitePlus | |
| Y465 | RIKDQyKVSVR | KH_1 | PhosphoSitePlus |
| S1252 | SEEFPsFGAQV | PhosphoSitePlus; HPRD | |
| T1058 | FKLSVtVDPKY | HPRD | |
| T296 | KKKKTtTIAVE | PhosphoSitePlus | |
| T111 | EIMQRtGAHLE | PhosphoSitePlus | |
| T1058 | FKLSVtVDPKY | KH_1 | PhosphoSitePlus |
| S1236 | APWTAsSSEKA | HPRD; phosphoELM | |
| S454 | HLIGKsGANIN | KH_1 | PhosphoSitePlus |
| Y582 | LVENSySISVP | PhosphoSitePlus | |
| S1237 | PWTASsSEKAP | HPRD; phosphoELM | |
| S468 | DQYKVsVRIPP | KH_1 | PhosphoSitePlus |
| S645 | RSRILsIQKDL | PhosphoSitePlus | |
| S1056 | RSFKLsVTVDP | KH_1 | PhosphoSitePlus |
| Y437 | INRMDyVEINI | HPRD; phosphoELM | |
| T297 | KKKTTtIAVEV | KH_1 | PhosphoSitePlus |
| S1246 | APDMSsSEEFP | PhosphoSitePlus | |
| Y437 | INRMDyVEINI | KH_1 | PhosphoSitePlus |
| S583 | VENSYsISVPI | KH_1 | PhosphoSitePlus |
| S581 | DLVENsYSISV | PhosphoSitePlus | |
| S126 | KDQGLsIMVSG | HPRD | |
| Y1210 | EALQVyMKPPA | PhosphoSitePlus | |
| S216 | EVLLIsAEQDK | PhosphoSitePlus; HPRD | |
| Y358 | ALTEVyAKANS | PhosphoSitePlus | |
| S756 | RKVRDsTGARV | HPRD | |
| T1261 | QVAPKtLPWGP | PhosphoSitePlus; HPRD | |
| S1056 | RSFKLsVTVDP | HPRD | |
| Dephosphorylation site |
| VIGLN_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000375837 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000312042 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000375836 | G778E | COSMIC | Skin Cancer | 21984974 |
| ENSP00000375837 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000312042 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000375836 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000375837 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000312042 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000375836 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000312042 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000375836 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000375836 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000312042 | G778E | COSMIC | Skin Cancer | 21984974 |
| ENSP00000375837 | G778E | COSMIC | Skin Cancer | 21984974 |
| ENSP00000375837 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| Differential expressed protein |
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|---|---|---|---|---|---|
| ENSP00000312042 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Up | 2 | 18646787 |
| ENSP00000312042 | Ovarian Cancer | Treatment (cisplatin-sensitive vs. cisplatin-resistant) | cell line | Down | 0.53 | 16319398 |
| ENSP00000312042 | Hepatocellular Carcinoma | Metastasis | cell line | Up | 1.8 | 19016532 |
| ENSP00000312042 | Breast Cancer | Normal vs. Cancer | tissue | Up | 0.45 | 20739354 |
| ENSP00000312042 | Gastric Cancer | Treatment (none vs. drug-resistant) | cell line | Up | 1.4 | 20625496 |
| Hyperphosphorylation site |
| VIGLN_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| PDPK1_HUMAN | VIGLN_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| STK11_HUMAN | VIGLN_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| Function Annotation |
| KEGG Pathway |
| VIGLN_HUMAN is not in KEGG pathway. |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0005634 | nucleus | IEA | cellular_component |
| GO:0006869 | lipid transport | IEA | biological_process |
| GO:0008203 | cholesterol metabolic process | IEA | biological_process |
| GO:0005886 | plasma membrane | TAS | cellular_component |
| GO:0008289 | lipid binding | TAS | molecular_function |
| GO:0003723 | RNA binding | IEA | molecular_function |
| GO:0034364 | high-density lipoprotein particle | IEA | cellular_component |
| GO:0005737 | cytoplasm | IDA | cellular_component |